ScholarWorks@Hanyang University: Browsing ScholarWorks

Browsing by Tomita, TetsuyaAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 5 of 5

SCIESCOPUS

Clinical Characteristics of Patients with Spondyloarthritis in Japan in Comparison with Other Regions of the World Go to Link open access

Kishimoto, Mitsumasa; Yoshida, Kazuki; Ichikawa, Naomi; Inoue, Hisashi; Kaneko, Yuko; Kawasaki, Taku; Matsui, Kazuo; Morita, Mitsuhiro; Suda, Masei; Tada, Kurisu, et al.

ArticleIssue Date2019CitationJOURNAL OF RHEUMATOLOGY, v.46, no.8, pp.896 - 903PublisherJ RHEUMATOL PUBL CO

SCIESCOPUS

Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity-results from the ENCOURAGE study, a prospective, international, multicenter randomized study Go to Link

Yamanaka, Hisashi; Nagaoka, Shouhei; Lee, Soo-Kon; Bae, Sang-Cheol; Kasama, Tsuyoshi; Kobayashi, Hitomi; Nishioka, Yuichi; Ueki, Yukitaka; Seto, Yohei; Nishinarita, Makoto, et al.

ArticleIssue Date2016CitationModern Rheumatology, v.26, no.5, pp 651 - 661PublisherSpringer Verlag

SCIESCOPUS

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial Go to Link

Deodhar, Atul; van der Heijde, Desiree; Gensler, Lianne S.; Kim, Tae-Hwan; Maksymowych, Walter P.; Ostergaard, Mikkel; Poddubnyy, Denis; Marzo-Ortega, Helena; Bessette, Louis; Tomita, Tetsuya, et al.

ArticleIssue Date2020CitationLANCET, v.395, no.10217, pp.53 - 64PublisherELSEVIER SCIENCE INC

Ixekizumab in Non-Radiographic Axial Spondyloarthritis: Primary Results from a Phase 3 Trial Go to Link

Deodhar, Atul; van der Heijde, Desiree; Gensler, Lianne; Kim, Tae-Hwan; Maksymowych, Walter P.; Ostergaard, Mikkel; Poddubnyy, Denis; Marzo-Ortega, Helena; Bessette, Louis; Tomita, Tetsuya, et al.

ConferenceIssue Date2019Citation2019 ACR/ARP Annual MeetingPublisherWILEYPlaceUS

SCISCIESCOPUS

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial Go to Link

van der Heijde, Desiree; Wei, James Cheng-Chung; Dougados, Maxime; Mease, Philip; Deodhar, Atul; Maksymowych, Walter P.; Van den Bosch, Filip; Sieper, Joachim; Tomita, Tetsuya; Landewe, Robert, et al.

ArticleIssue Date2018CitationThe Lancet, v.392, no.10163, pp 2441 - 2451PublisherElsevier Science Inc.

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Tomita, TetsuyaAuthor

BROWSE